Company Profile
Anqing Bayee Biotech Co., Ltd, headquartered in Anqing, China, is a distinguished chemical enterprise with a legacy dating back to 1997. Over the years, it has blossomed into a preeminent provider of chemical products and services, commanding a prominent position within the region.
Bayee Biotech specializes in the research, development, and production of a diverse array of chemical products, spanning diagnostic reagents, electronics chemicals, food additives, and more. These products find extensive application across diverse industrial sectors, encompassing pharmaceuticals, biotechnology, and electronics.
Beyond its extensive product portfolio, Bayee Biotech extends a gamut of services, comprising research and development, custom synthesis, and technical consultancy. Anchored by a team of adept scientists and engineers, the company is fervently committed to delivering high-quality products and services tailored to meet the unique demands of its clientele.
The company's manufacturing facility, situated in Anqing, is equipped with cutting-edge technology and state-of-the-art equipment, meticulously designed to uphold the pinnacle of product quality. These facilities are meticulously aligned with international quality standards and regulations, inclusive of ISO 9001:2015 and GLP compliance.
Bayee Biotech has etched its reputation as a reliable partner, resonating with customers both within China and across international borders. The company's unwavering dedication to quality, innovation, and customer service has not only distinguished it within the chemical industry but also positioned it as a beacon of excellence.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan |
Furan,3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-,(3S)-;(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran;(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran;(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]oxolane |
915095-94-2 | Inquiry | |
4-(4-bromo-3-(hydroxymethyl)phenoxy)benzonitrile |
4-(4-bromo-3-(hydroxymethyl)phenoxy)benzonitrile;4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile;SCHEMBL595139;KS-00000SOO;CS-B0833;AKOS027324076;ZINC114176713;AK316795;DA-21536;DS-11465 |
906673-45-8 | Inquiry | |
5-Methyl-3,4-diphenylisoxazole |
5-Methyl-3,4-diphenylisoxazole;5-Methyl-3,4-diphenyl-isoxazole;Isoxazole, 5-methyl-3,4-diphenyl-;5-methyl-3,4-diphenyl-1,2-oxazole;Isoxazole, 5-Methyl-3,4-diphenyl- (Parecoxib sodiuM inteMediate);CHEMBL365033;SCHEMBL2277199;3,4-Diphenyl-5-methylisoxazole;3,4-diphenyl-5-methyl isoxazole;3,4-diphenyl-5-methyl-isoxazole |
37928-17-9 | Inquiry | |
Crisaborole API & Intermediates |
Benzonitrile,4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-;4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile;AN 2728;Crisaborole;4-[(1-Hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile;Eucrisa;Staquis;1187189-21-4;1073669-75-6 |
906673-24-3 | Inquiry | |
Empagliflozin API & Intermediates |
D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol;Empagliflozin;BI 10773;Jardiance;1240076-01-0;1314556-33-6 |
864070-44-0 | Inquiry | |
Parecoxib Sodium API & Intermediates |
Propanamide,N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-,sodium salt (1:1);Propanamide,N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-,sodium salt;SC 69124A;Parecoxib sodium;Dynastat;Rayzon;197502-82-2 |
198470-85-8 | Inquiry | |
Rivaroxaban API & Intermediate |
2-Thiophenecarboxamide,5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;Rivaroxaban;BAY 59-7939;5-Chloro-N-[[(S)-3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]-thiophene-2-carboxamide;Xarelto;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl]methyl]-2-thiophenecarboxamide;5-Chloro-N-([(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl]-methyl)-2-thiophenecarboxamide;(S)-Rivaroxaban;869880-21-7;931117-62-3;1807854-46-1 |
366789-02-8 | Inquiry | |
Ruxolitinib API & Intermediates |
1H-Pyrazole-1-propanenitrile,β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-,(βR)-;(βR)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;Ruxolitinib;INCB 018424;(3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile;INC 424;(R)-3-[4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-cyclopentylpropanenitrile;1138325-12-8 |
941678-49-5 | Inquiry | |
Tofacitinib citrate API & Intermediates |
1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tasocitinib citrate;CP 690500-10;Tofacitinib citrate;CP 690550-10;Xeljanz;Xeljanz XR |
540737-29-9 | Inquiry | |
Vonoprazan Fumarate API & Intermediate |
1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine;AK-438;Vonaprazan(TAK-438);vonoprazan(tak-438);vonoprazan(tak-438)1260141-27-2;fuMarate vonoprazan;5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate TAK 438;vonaprazan(TK-438) |
1260141-27-2 | Inquiry |